Fortive Corporation Peer Comparison

Metric Value Ranking
Market Cap $25.7 Billion 2/13 IIVI
$30.5B		 FTV
$25.7B		 TDY
$20.0B		 TRMB
$13.6B		 COHR
$11.6B		 MKSI
$7.3B		 NOVT
$6.0B		 BMI
$6.0B		 ST
$5.2B		 ITRI
$4.5B		 ESE
$3.0B		 MLAB
$657.5M		 VPG
$318.0M
Gross Margin 60% 3/13 IIVI
100%		 COHR
100%		 FTV
60%		 TRMB
60%		 MLAB
58%		 TDY
43%		 VPG
42%		 MKSI
41%		 NOVT
41%		 BMI
39%		 ESE
37%		 ITRI
34%		 ST
26%
Profit Margin 13% 5/13 IIVI
100%		 COHR
100%		 TRMB
100%		 BMI
15%		 FTV
13%		 TDY
13%		 ESE
11%		 ITRI
8%		 ST
7%		 NOVT
6%		 VPG
6%		 MLAB
6%		 MKSI
3%
EBITDA margin 28% 3/13 IIVI
132%		 COHR
132%		 FTV
28%		 MKSI
25%		 BMI
23%		 ESE
21%		 ST
19%		 MLAB
19%		 NOVT
18%		 TDY
18%		 TRMB
15%		 ITRI
13%		 VPG
13%
Quarterly Revenue $1.6 Billion 1/13 FTV
$1.6B		 TDY
$1.4B		 ST
$1.0B		 MKSI
$887.0M		 TRMB
$870.8M		 ITRI
$609.1M		 ESE
$260.8M		 NOVT
$235.9M		 BMI
$216.7M		 IIVI
$95.9M		 COHR
$95.9M		 VPG
$77.4M		 MLAB
$58.2M
Quarterly Earnings $195.1 Million 2/13 TRMB
$1.3B 		FTV
$195.1M 		TDY
$180.2M 		IIVI
$126.6M 		COHR
$126.6M 		ST
$71.7M 		ITRI
$51.3M 		BMI
$33.1M 		ESE
$29.2M 		MKSI
$23.0M 		NOVT
$13.8M 		VPG
$4.6M 		MLAB
$3.4M
Quarterly Free Cash Flow $279.7 Million 1/13 FTV
$279.7M 		ST
$97.7M 		TRMB
$73.3M 		MKSI
$64.0M 		ITRI
$44.8M 		NOVT
$35.3M 		BMI
$34.1M 		ESE
$24.9M 		MLAB
$9.5M 		VPG
$4.9M 		IIVI
-$0 		COHR
-$0 		TDY
-$0
Trailing 4 Quarters Revenue $5.5 Billion 2/13 TDY
$5.6B		 FTV
$5.5B		 ST
$4.0B		 TRMB
$3.7B		 MKSI
$3.6B		 IIVI
$3.5B		 COHR
$3.5B		 ITRI
$2.4B		 ESE
$1.0B		 NOVT
$899.9M		 BMI
$781.6M		 VPG
$333.5M		 MLAB
$223.7M
Trailing 4 Quarters Earnings $885.7 Million 2/13 FTV
$1.6B 		TDY
$1.4B 		ST
$1.0B 		MKSI
$887.0M 		TRMB
$870.8M 		ITRI
$609.1M 		ESE
$260.8M 		NOVT
$235.9M 		BMI
$216.7M 		IIVI
$95.9M 		COHR
$95.9M 		VPG
$77.4M 		MLAB
$58.2M
Quarterly Earnings Growth -7% 11/13 TRMB
2852% 		MLAB
717% 		IIVI
171% 		COHR
171% 		ITRI
112% 		MKSI
101% 		BMI
47% 		ST
46% 		ESE
5% 		TDY
-3% 		FTV
-7% 		NOVT
-34% 		VPG
-44%
Annual Earnings Growth 21% 9/13 ITRI
1675% 		TRMB
251% 		IIVI
111% 		COHR
111% 		MKSI
100% 		BMI
40% 		TDY
22% 		ESE
22% 		FTV
21% 		NOVT
-18% 		VPG
-28% 		ST
-97% 		MLAB
-19594%
Quarterly Revenue Growth 2% 6/13 BMI
23% 		MLAB
15% 		ITRI
13% 		ESE
5% 		NOVT
3% 		FTV
2% 		ST
-2% 		TDY
-4% 		TRMB
-12% 		MKSI
-12% 		VPG
-15% 		IIVI
-92% 		COHR
-92%
Annual Revenue Growth -7% 10/13 BMI
20% 		ITRI
16% 		ESE
7% 		MKSI
6% 		MLAB
3% 		NOVT
1% 		ST
0% 		TDY
0% 		TRMB
-1% 		FTV
-7% 		VPG
-7% 		IIVI
-29% 		COHR
-29%
Cash On Hand $644.1 Million 7/13 ST
$1.0B 		TRMB
$944.1M 		IIVI
$926.0M 		COHR
$926.0M 		ITRI
$920.6M 		MKSI
$850.0M 		FTV
$644.1M 		TDY
$443.2M 		BMI
$226.2M 		NOVT
$98.5M 		VPG
$84.1M 		ESE
$63.0M 		MLAB
$28.5M
Short Term Debt $383.9 Million 3/13 ST
$702.7M 		TRMB
$400.0M 		FTV
$383.9M 		TDY
$150.5M 		IIVI
$114.4M 		COHR
$114.4M 		MKSI
$87.0M 		VPG
$36.0M 		ESE
$26.0M 		NOVT
$15.3M 		ITRI
$12.8M 		MLAB
$6.7M 		BMI
$1.4M
Long Term Debt $3.4 Billion 4/13 MKSI
$4.8B		 IIVI
$4.2B		 COHR
$4.2B		 FTV
$3.4B		 ST
$3.2B		 TDY
$2.6B		 TRMB
$1.4B		 ITRI
$1.2B		 NOVT
$477.1M		 ESE
$153.0M		 MLAB
$138.9M		 VPG
$21.3M		 BMI
$5.2M
PE 29.03 8/13 IIVI
1571.10		 MKSI
806.33		 ST
622.08		 COHR
599.92		 NOVT
97.27		 BMI
53.10		 ESE
30.47		 FTV
29.03		 ITRI
23.86		 TDY
22.72		 VPG
15.14		 TRMB
9.00		 MLAB
-1.00
PS 4.66 4/13 IIVI
8.75		 BMI
7.67		 NOVT
6.72		 FTV
4.66		 TRMB
3.66		 TDY
3.60		 COHR
3.34		 ESE
3.03		 MLAB
2.94		 MKSI
2.03		 ITRI
1.90		 ST
1.28		 VPG
0.95
PB 2.45 8/13 BMI
10.64		 NOVT
8.61		 MLAB
4.36		 IIVI
3.84		 ITRI
3.55		 MKSI
3.25		 ESE
2.54		 FTV
2.45		 TRMB
2.41		 TDY
2.15		 ST
1.71		 COHR
1.47		 VPG
0.97
PC 39.92 4/13 NOVT
61.41		 ESE
48.15		 TDY
45.14		 FTV
39.92		 IIVI
32.95		 BMI
26.50		 MLAB
23.09		 TRMB
14.40		 COHR
12.58		 MKSI
8.54		 ST
4.99		 ITRI
4.86		 VPG
3.78
Liabilities to Equity 0.65 9/13 MKSI
2.97		 IIVI
2.77		 COHR
2.77		 MLAB
1.92		 ST
1.72		 ITRI
1.63		 NOVT
0.99		 TRMB
0.70		 FTV
0.65		 TDY
0.53		 ESE
0.52		 VPG
0.42		 BMI
0.39
ROA 0.05 6/13 TRMB
16% 		BMI
14% 		ITRI
6% 		TDY
6% 		ESE
6% 		FTV
5% 		VPG
5% 		NOVT
4% 		IIVI
0% 		COHR
0% 		MKSI
0% 		ST
0% 		MLAB
-57%
ROE 0.08 6/13 TRMB
27% 		BMI
20% 		ITRI
15% 		NOVT
9% 		TDY
9% 		FTV
8% 		ESE
8% 		VPG
6% 		IIVI
1% 		COHR
1% 		MKSI
0% 		ST
0% 		MLAB
-166%
Current Ratio 2.55 5/13 BMI
3.58		 VPG
3.41		 ESE
2.93		 TDY
2.90		 FTV
2.55		 TRMB
2.42		 IIVI
2.21		 COHR
2.21		 NOVT
2.01		 ITRI
1.62		 ST
1.58		 MLAB
1.52		 MKSI
1.34
Quick Ratio 0.10 10/13 IIVI
1571.10		 MKSI
806.33		 ST
622.08		 COHR
599.92		 NOVT
97.27		 BMI
53.10		 ESE
30.47		 FTV
29.03		 ITRI
23.86		 TDY
22.72		 VPG
15.14		 TRMB
9.00		 MLAB
-1.00
Long Term Debt to Equity 0.32 8/13 MKSI}
2.16		 IIVI}
1.77		 COHR}
1.77		 ST}
1.05		 ITRI}
1.00		 MLAB}
0.92		 NOVT}
0.68		 FTV}
0.32		 TDY}
0.28		 TRMB}
0.25		 ESE}
0.13		 VPG}
0.07		 BMI}
0.01
Debt to Equity 0.38 8/13 MKSI
2.29		 IIVI
1.82		 COHR
1.82		 ST
1.29		 ITRI
1.02		 MLAB
0.97		 NOVT
0.77		 FTV
0.38		 TRMB
0.34		 TDY
0.30		 ESE
0.19		 VPG
0.18		 BMI
0.01
Burn Rate 17.54 2/13 ITRI
625.91		 FTV
17.54		 VPG
16.03		 IIVI
13.31		 COHR
13.31		 NOVT
10.75		 MLAB
7.41		 ST
4.48		 MKSI
4.43		 TRMB
-0.81		 ESE
-3.80		 BMI
-6.96		 TDY
-12.08
Cash to Cap 0.03 9/13 VPG
0.26		 ITRI
0.21		 ST
0.20		 MKSI
0.12		 COHR
0.08		 TRMB
0.07		 BMI
0.04		 MLAB
0.04		 FTV
0.03		 IIVI
0.03		 NOVT
0.02		 TDY
0.02		 ESE
0.02
CCR 1.43 4/13 MLAB
2.82		 MKSI
2.78		 NOVT
2.57		 FTV
1.43		 ST
1.36		 VPG
1.06		 BMI
1.03		 ITRI
0.87		 ESE
0.85		 TRMB
0.06		 IIVI
 COHR
 TDY
EV to EBITDA 66.20 8/13 IIVI}
267.70		 NOVT}
153.05		 COHR}
118.67		 BMI}
116.42		 TRMB}
109.19		 TDY}
90.56		 MLAB}
70.14		 FTV}
66.20		 ITRI}
61.83		 ESE}
59.27		 MKSI}
52.40		 ST}
40.43		 VPG}
29.64
EV to Revenue 5.26 4/13 IIVI
9.71		 BMI
7.39		 NOVT
7.21		 FTV
5.26		 COHR
4.31		 TDY
4.03		 TRMB
3.92		 MLAB
3.46		 MKSI
3.22		 ESE
3.20		 ITRI
2.05		 ST
1.99		 VPG
0.87

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions